23Andme Price To Sales Ratio from 2010 to 2024
| ME Stock | USD 4.91 0.43 8.05% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 22.84146219 | Current Value 21.7 | Quarterly Volatility 82.61471956 |
Check 23Andme Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 23Andme Holding's main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.9 M, Interest Expense of 11.6 M or Selling General Administrative of 104.6 M, as well as many indicators such as Price To Sales Ratio of 21.7, Dividend Yield of 0.0 or PTB Ratio of 25.28. 23Andme financial statements analysis is a perfect complement when working with 23Andme Holding Valuation or Volatility modules.
23Andme | Price To Sales Ratio |
Latest 23Andme Holding's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of 23Andme Holding Co over the last few years. Price to Sales Ratio is figured by comparing 23Andme Holding stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on 23Andme Holding sales, a figure that is much harder to manipulate than other 23Andme Holding Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. 23Andme Holding's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 23Andme Holding's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.64 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
23Andme Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 162.73 | |
| Geometric Mean | 131.80 | |
| Coefficient Of Variation | 50.77 | |
| Mean Deviation | 58.10 | |
| Median | 180.68 | |
| Standard Deviation | 82.61 | |
| Sample Variance | 6,825 | |
| Range | 317 | |
| R-Value | (0.44) | |
| Mean Square Error | 5,897 | |
| R-Squared | 0.20 | |
| Significance | 0.1 | |
| Slope | (8.21) | |
| Total Sum of Squares | 95,553 |
23Andme Price To Sales Ratio History
About 23Andme Holding Financial Statements
23Andme Holding stakeholders use historical fundamental indicators, such as 23Andme Holding's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although 23Andme Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in 23Andme Holding's assets and liabilities are reflected in the revenues and expenses on 23Andme Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 23Andme Holding Co. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 22.84 | 21.70 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| F | Ford Motor | |
| CRM | Salesforce |
Check out the analysis of 23Andme Holding Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (26.20) | Revenue Per Share 8.224 | Quarterly Revenue Growth (0.34) | Return On Assets (0.26) | Return On Equity (1.54) |
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.